Research page

CJC-1295 w DAC

CJC-1295 w DAC 5 mg. For research use only
Calculate dose

Specification

NameCJC-1295 w DAC
Catalog sizes5 mg
Adopted bacteriostatic water5 mg + 2.0 mL = 2.5 mg/mL

Overview

CJC-1295 with DAC is a long-acting GHRH analog in the literature. The TRACE vial is 5 mg. The study cited evaluated that long-acting form in healthy adults.

Mechanism under study

The DAC complex was studied because it prolongs the analog’s time in circulation. The 2006 paper described a rise in growth hormone and IGF-1 during that study’s window. It is not a schedule for this vial.

What published research has reported

TRACE cites the paper by Teichman and colleagues (2006) and does not add an amount for use. The vial is not an approved medicine.

Composition and mass

5 mg vial. Adopted bacteriostatic water: 2 mL (2.5 mg/mL).

Reconstitution

mgmLmg/mL
52.02.5In the catalog

Calculate dose

Storage and handling

Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.

Regulatory status

Research material. Not growth hormone and not an approved medicine.

References